Sanofi SNY
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -128.46% | -26.74% | 126.99% | ||
| Total Depreciation and Amortization | 707.35% | -141.53% | 121.91% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -52.16% | 125.54% | -1,527.41% | ||
| Change in Net Operating Assets | 191.57% | 203.01% | -- | ||
| Cash from Operations | -8.53% | 164.22% | -24.67% | ||
| Capital Expenditure | -307.63% | 203.01% | -- | ||
| Sale of Property, Plant, and Equipment | 294.32% | -203.01% | -- | ||
| Cash Acquisitions | -1,838.60% | 203.01% | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 181.49% | -198.48% | 1,552.61% | ||
| Cash from Investing | 76.54% | -198.03% | 1,420.72% | ||
| Total Debt Issued | 188.03% | -200.00% | -- | ||
| Total Debt Repaid | -304.49% | 200.00% | -- | ||
| Issuance of Common Stock | -95.58% | 13,703.45% | -- | ||
| Repurchase of Common Stock | -17,244.83% | 99.28% | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 199.80% | -1,175.82% | 187.33% | ||
| Cash from Financing | -122.91% | 69.65% | -609.94% | ||
| Foreign Exchange rate Adjustments | 158.08% | 43.81% | -18.63% | ||
| Miscellaneous Cash Flow Adjustments | -- | -100.00% | 323.35% | ||
| Net Change in Cash | 80.73% | -190.23% | 1,344.57% | ||